Literature DB >> 19922794

Impaired TNF-alpha control of IP3R-mediated Ca2+ release in Alzheimer's disease mouse neurons.

Keigan M Park1, David I Yule, William J Bowers.   

Abstract

The misguided control of inflammatory signaling has been previously implicated in the pathogenesis of several neurological disorders, including Alzheimer's disease (AD). Induction of tumor necrosis factor-alpha (TNF-alpha), a central mediator of neuroinflammation, occurs commensurate with the onset of early disease in 3xTg-AD mice, which develop both amyloid plaque and neurofibrillary tangle pathologies in an age- and region-dependent pattern. Herein, we describe regulation inherent to 3xTg-AD neurons, which results in the loss of TNF-alpha mediated enhancement of inositol 1,4,5 trisphosphate (IP3R)-mediated Ca2+ release. This modulation also leads to significant down-regulation of IP3R signaling following protracted cytokine exposure. Through the experimental isolation of each AD-related transgene, it was determined that expression of the PS1M146V transgene product is responsible for the loss of the TNF-alpha effect on IP3R-mediated Ca2+ release. Furthermore, it was determined that the suppression of TNF-alpha receptor expression occurred in the presence of the presenilin transgene. Our findings attribute this familial AD mutation to suppressing a Ca2+-regulated signal cascade potentially intended to "inform" neurons of proximal neuroinflammatory events and trigger compensatory responses for protection of neural transmission.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19922794      PMCID: PMC2794907          DOI: 10.1016/j.cellsig.2009.11.006

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  26 in total

1.  Enhanced ryanodine receptor recruitment contributes to Ca2+ disruptions in young, adult, and aged Alzheimer's disease mice.

Authors:  Grace E Stutzmann; Ian Smith; Antonella Caccamo; Salvatore Oddo; Frank M Laferla; Ian Parker
Journal:  J Neurosci       Date:  2006-05-10       Impact factor: 6.167

Review 2.  The role of calcium in apoptosis.

Authors:  P Nicotera; S Orrenius
Journal:  Cell Calcium       Date:  1998 Feb-Mar       Impact factor: 6.817

3.  Tumor necrosis-factor-alpha (TNF-alpha) induces rapid insertion of Ca2+-permeable alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate (AMPA)/kainate (Ca-A/K) channels in a subset of hippocampal pyramidal neurons.

Authors:  Fumio Ogoshi; Hong Zhen Yin; Yuvarani Kuppumbatti; Bora Song; Simin Amindari; John H Weiss
Journal:  Exp Neurol       Date:  2005-06       Impact factor: 5.330

4.  Tumor necrosis factor-alpha-mediated regulation of the inositol 1,4,5-trisphosphate receptor promoter.

Authors:  Keigan M Park; David I Yule; William J Bowers
Journal:  J Biol Chem       Date:  2009-08-07       Impact factor: 5.157

5.  Up-regulation of inositol 1,4,5-trisphosphate receptor type 1 is responsible for a decreased endoplasmic-reticulum Ca2+ content in presenilin double knock-out cells.

Authors:  Nael Nadif Kasri; Sarah L Kocks; Leen Verbert; Sébastien S Hébert; Geert Callewaert; Jan B Parys; Ludwig Missiaen; Humbert De Smedt
Journal:  Cell Calcium       Date:  2006-05-03       Impact factor: 6.817

6.  Cleavage of p75 neurotrophin receptor by alpha-secretase and gamma-secretase requires specific receptor domains.

Authors:  Niccolò Zampieri; Chong-Feng Xu; Thomas A Neubert; Moses V Chao
Journal:  J Biol Chem       Date:  2005-02-08       Impact factor: 5.157

7.  Ca2+ signaling in mouse cortical neurons studied by two-photon imaging and photoreleased inositol triphosphate.

Authors:  Grace E Stutzmann; Frank M LaFerla; Ian Parker
Journal:  J Neurosci       Date:  2003-02-01       Impact factor: 6.167

8.  Increased intraneuronal resting [Ca2+] in adult Alzheimer's disease mice.

Authors:  José R Lopez; Alvin Lyckman; Salvatore Oddo; Frank M Laferla; Henry W Querfurth; Alexander Shtifman
Journal:  J Neurochem       Date:  2007-11-16       Impact factor: 5.372

9.  Tumor necrosis factor-alpha potentiates intraneuronal Ca2+ signaling via regulation of the inositol 1,4,5-trisphosphate receptor.

Authors:  Keigan M Park; David I Yule; William J Bowers
Journal:  J Biol Chem       Date:  2008-10-06       Impact factor: 5.157

10.  Tumor necrosis factor-induced downregulation of its receptors in HeLa cells.

Authors:  M Tsujimoto; J Vilcek
Journal:  J Biochem       Date:  1987-12       Impact factor: 3.387

View more
  6 in total

1.  The Ca(2+) channel inhibitor 2-APB reverses β-amyloid-induced LTP deficit in hippocampus by blocking BAX and caspase-3 hyperactivation.

Authors:  Wei-Yan Hu; Zhi-Yong He; Lu-Jun Yang; Ming Zhang; Da Xing; Zhi-Cheng Xiao
Journal:  Br J Pharmacol       Date:  2015-02-27       Impact factor: 8.739

2.  PKCα signaling pathway involves in TNF-α-induced IP3R1 expression in human mesangial cells.

Authors:  Yu-Rong Wang; Huan Zhang; Hui Sun; Pei Liu
Journal:  World J Emerg Med       Date:  2012

3.  Tumor necrosis factor alpha maintains denervation-induced homeostatic synaptic plasticity of mouse dentate granule cells.

Authors:  Denise Becker; Nadine Zahn; Thomas Deller; Andreas Vlachos
Journal:  Front Cell Neurosci       Date:  2013-12-18       Impact factor: 5.505

Review 4.  Integration of modeling with experimental and clinical findings synthesizes and refines the central role of inositol 1,4,5-trisphosphate receptor 1 in spinocerebellar ataxia.

Authors:  Sherry-Ann Brown; Leslie M Loew
Journal:  Front Neurosci       Date:  2015-01-21       Impact factor: 4.677

Review 5.  Calcium Ions Aggravate Alzheimer's Disease Through the Aberrant Activation of Neuronal Networks, Leading to Synaptic and Cognitive Deficits.

Authors:  Pei-Pei Guan; Long-Long Cao; Yi Yang; Pu Wang
Journal:  Front Mol Neurosci       Date:  2021-12-02       Impact factor: 5.639

6.  Anti-aggregating effect of the naturally occurring dipeptide carnosine on aβ1-42 fibril formation.

Authors:  Alessandra Aloisi; Amilcare Barca; Alessandro Romano; Sara Guerrieri; Carlo Storelli; Rosaria Rinaldi; Tiziano Verri
Journal:  PLoS One       Date:  2013-07-03       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.